Alpha-1 Antitrypsin Deficiency: Fact or Fiction? | Dr. Kenneth Chapman

Dr. Kenneth Chapman dispels common myths about alpha-1 antitrypsin deficiency (AATD), emphasizing that it is underdiagnosed, not limited to the lungs, and more prevalent in clinical practice than many assume. He highlights the importance of broad screening, early diagnosis, and available treatments, including augmentation therapy, to improve patient outcomes

For disease awareness only, not for promotional use. The opinions expressed in this video are those of the speaker and do not necessarily reflect those of Takeda.